Skip to main content

Table 6 Results from Statistical Modelling (BB Model)

From: Comparing the mapping between EQ-5D-5L, EQ-5D-3L and the EORTC-QLQ-C30 in non-small cell lung cancer patients

  EQ-5D-5L EQ-5D-3L
  Estimate SE P-value Estimate SE P-value
Intercept -1.51144 0.000060 <0.001 -0.0123 .003893 0.00248
Physical Functioning 0.02254* 0.004666 <0.001 0.08711 .002940 <0.001*
Role Functioning 0.009619* 0.004550 0.03867 0.00421 .002685 0.12215
Emotional Functioning 0.01904* 0.003192 <0.0001 0.00661 .002007 0.00166*
Cognitive Functioning -0.00633 0.003312 0.06076 -0.00425 .002111 0.04858*
Social Functioning -0.00013 0.002758 0.97120 -0.00035 .001973 0.85980
Global Health Status / QoL 0.001652 0.002772 0.55344 -0.00197 .001913 0.30724
Fatigue 0.003561 0.005282 0.50279 0.00443 .002979 0.14223
Nausea / Vomiting 0.000452 0.004514 0.92057 -0.00146 .002700 0.59069
Pain -0.03479* 0.003512 <0.001 -0.01039 .001910 <0.001*
Dyspnoea -0.00806* 0.002800 0.00553 0.00015 .001759 0.93233
Insomnia 0.002047 0.002388 0.39474 0.00193 .001491 0.20048
Appetite loss 0.005383* 0.002446 0.03161 0.0002 .001415 0.88807
Constipation 0.000454 0.002052 0.82565 0.0014 .001386 0.31650
Diarrhoea 0.000353 0.00274 0.20705 0.00393 .001841 0.03688*
Financial Problems -0.004324 0.002182 0.07174 -0.00113 .001292 0.38527
  1. *Statistically significant at the two-sided 5 % level